Previous Webinar

The Power of High-Content Imaging to probe Ligand Binding

May 24, 2022, 10:00 am EDT / 4:00 pm CEST

Program

Host and moderator: Stefan Prechtl, CELLIMA Scientific Services

10 min	Stefan Prechtl, CELLIMA Scientific Services	High-Content Imaging in Medicinal Research – A Brief Overview
40 min	Eugenio Fava, DZNE, Bonn	From target to system: looking to the immune system for drug discovery in CNS
10 min		Audience Q&A

BIO SKETCHES

Stefan Prechtl, CELLIMA Scientific Services

Stefan is a passionate scientist with proven experience in pharmaceutical drug discovery. He holds a degree in biology and a PhD in immunology. He worked 20 years in industrial research, with scientific positions at SCHERING, BAYER and NUVISAN ICB. In 2021, he started his own business and founded CELLIMA, which offers a specialized range of scientific services in the field of high-content imaging. During his scientific career, he acquired in-depth knowledge and expertise in high-throughput screening, high-content imaging including automated image analysis and machine learning approaches. As a motivated researcher, he is constantly exploring the boundaries of his fields of work and is always looking for new challenges.

Eugenio Fava, DZNE, Bonn

Eugenio Fava is an enthusiastic scientist with experience in neuroscience and drug discovery. Eugenio is leading the Core Research Facilities & Services at DZNE (Deutsches Zentrum für Neurodegenerative Erkrankungen - German Center for Neurodegenerative Diseases) where he established a set of innovative platforms with the focus to transfer bench scale research to an industrial standard for preclinical drug discovery. Eugenio aims to develop and use innovative technologies on both technology and cell-based assays to achieve the delivery of therapeutical intervention in CNS diseases.